Skip to main navigation Skip to search Skip to main content

An Open-Label Study of Dupilumab in Patients with Atopic Dermatitis Who Participated in Previous Dupillumab Clinical Trials

Project: Research

Project Details

StatusFinished
Effective start/end date09/1/15 → 08/31/18

Funding

  • Regeneron Pharmaceuticals Incorporated: $70,727.76